Annual Accounts Receivable
$5.00 M
+$3.18 M+175.03%
31 December 2022
Summary:
Catalyst Biosciences annual accounts receivable is currently $5.00 million, with the most recent change of +$3.18 million (+175.03%) on 31 December 2022. During the last 3 years, it has risen by +$3.18 million (+175.03%).CBIO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$0.00
$0.000.00%
30 September 2023
Summary:
Catalyst Biosciences quarterly accounts receivable is currently $0.00, unchanged on 30 September 2023.CBIO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +175.0% | -100.0% |
| 5 y5 years | -66.7% | -100.0% |
CBIO Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -78.6% | -100.0% |
Catalyst Biosciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $0.00(0.0%) |
| June 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $5.00 M(0.0%) |
| Dec 2022 | $5.00 M(+175.0%) | $5.00 M(0.0%) |
| Sept 2022 | - | $5.00 M(0.0%) |
| June 2022 | - | $5.00 M(+786.5%) |
| Mar 2022 | - | $564.00 K(-69.0%) |
| Dec 2021 | $1.82 M(-45.1%) | $1.82 M(+63.2%) |
| Sept 2021 | - | $1.11 M(-43.5%) |
| June 2021 | - | $1.97 M(+95.9%) |
| Mar 2021 | - | $1.01 M(-69.6%) |
| Dec 2020 | $3.31 M(-77.9%) | $3.31 M(+113.1%) |
| Sept 2020 | - | $1.55 M(-21.8%) |
| June 2020 | - | $1.99 M(+45.5%) |
| Mar 2020 | - | $1.37 M(-90.9%) |
| Dec 2019 | $15.00 M(>+9900.0%) | $15.00 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2017 | - | $52.00 K(-61.5%) |
| June 2017 | - | $135.00 K(-40.5%) |
| Mar 2017 | - | $227.00 K(+632.3%) |
| Dec 2016 | $31.00 K(-93.7%) | $31.00 K(-69.3%) |
| Sept 2016 | - | $101.00 K(-78.1%) |
| June 2016 | - | $462.00 K(+3.1%) |
| Mar 2016 | - | $448.00 K(-8.9%) |
| Dec 2015 | $492.00 K | $492.00 K(-24.1%) |
| Sept 2015 | - | $648.00 K(+6380.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $10.00 K(-85.3%) |
| Mar 2015 | - | $68.00 K(-51.8%) |
| Dec 2014 | $141.00 K(-49.3%) | $141.00 K(+147.4%) |
| Sept 2014 | - | $57.00 K(+103.6%) |
| June 2014 | - | $28.00 K(-91.8%) |
| Mar 2014 | - | $343.00 K(+23.4%) |
| Dec 2013 | $278.00 K(-79.9%) | $278.00 K(+768.8%) |
| Sept 2013 | - | $32.00 K(-70.4%) |
| June 2013 | - | $108.00 K(-71.8%) |
| Mar 2013 | - | $383.00 K(-72.2%) |
| Dec 2012 | $1.38 M(+533.0%) | $1.38 M(+533.0%) |
| Dec 2011 | $218.00 K(-94.8%) | $218.00 K(-87.6%) |
| Sept 2009 | - | $1.76 M(+4.4%) |
| June 2009 | - | $1.69 M(-53.8%) |
| Mar 2009 | - | $3.65 M(+28.3%) |
| Sept 2008 | - | $2.84 M(+0.1%) |
| June 2008 | - | $2.84 M(+57.7%) |
| Mar 2008 | - | $1.80 M(-57.1%) |
| Dec 2007 | $4.20 M(-82.0%) | $4.20 M(+77.3%) |
| Sept 2007 | - | $2.37 M(+5.5%) |
| June 2007 | - | $2.24 M(+7.7%) |
| Mar 2007 | - | $2.08 M(-91.1%) |
| Dec 2006 | $23.37 M(>+9900.0%) | $23.37 M(+1880.7%) |
| Sept 2006 | - | $1.18 M(-6.6%) |
| June 2006 | - | $1.26 M(+54.6%) |
| Mar 2006 | - | $816.50 K(+590.8%) |
| Dec 2005 | $118.20 K | $118.20 K |
FAQ
- What is Catalyst Biosciences annual accounts receivable?
- What is the all time high annual accounts receivable for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Catalyst Biosciences?
What is Catalyst Biosciences annual accounts receivable?
The current annual accounts receivable of CBIO is $5.00 M
What is the all time high annual accounts receivable for Catalyst Biosciences?
Catalyst Biosciences all-time high annual accounts receivable is $23.37 M
What is Catalyst Biosciences quarterly accounts receivable?
The current quarterly accounts receivable of CBIO is $0.00
What is the all time high quarterly accounts receivable for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly accounts receivable is $23.37 M